Correcting & Replacing — Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium
In a press release issued earlier this afternoon, the time zone of the FPWR Research…
News
Pioneering Transformation: Unveiling the Trailblazing Winners of the Inaugural WiT Travel Changemakers Awards 2023
SINGAPORE, Oct 5, 2023 – (ACN Newswire) – The Asia Travel Technology Industry Association (ATTIA)…
Snowden Lane Partners Welcomes The Torres Group, Adds $200 Million in Client Assets
Former UBS Team Joins Snowden Lane’s New York Office NEW YORK–(BUSINESS WIRE)–Snowden Lane Partners, an…
1859 Announces the Formation of Its Scientific Advisory Board
Appointees Include Two 2024 ACS National Award Recipients, AIML Trailblazer, and Serial Biotech Co-founder. SAN…
U.S. Bank Names Ariel Meyerstein as Head of ESG Program Office
MINNEAPOLIS–(BUSINESS WIRE)–U.S. Bank has named Ariel Meyerstein as the head of its Environmental, Social and…
ELES and proteanTecs Partner to Enhance Reliability Testing with Deep Data Analytics
Collaboration enables SoC manufacturers to improve their qualification envelope to achieve lifetime reliability, shorten their…
Judging Panel of International Industry Experts Announced For 2024 FICO Decisions Awards
Awards honor FICO customers achieving outstanding results with AI, decision management and digital transformation BOZEMAN,…
Nanobiotix Announces the Presentation of the Final Efficacy Analysis From Phase 1 Cohort Expansion Evaluating NBTXR3 in Locally Advanced Head and Neck Cancer Showing Median Progression-Free Survival of 16.9 Months and Median Overall Survival of 23.1 Months
Results presented in an oral presentation by Professor Christophe Le Tourneau, MD, PhD, of Institut…
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s…
ALX Oncology Announces Proposed Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023
EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast
Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to…
QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
QuantiFERON-EBV RUO to help researchers understand Epstein-Barr virus (EBV) infections and related malignancies, offering a…
Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology…
Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions
DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13
Management to host conference call and webcast on October 13 at 4:30 PM ET with…
Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium
REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno or the…
PHAXIAM Receives Compliance Notice from Nasdaq
PHAXIAM Receives Compliance Notice from Nasdaq Lyon (France) et Cambridge (MA, US), October 4, 2023,…
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance ROCKVILLE,…